ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses
Authors:
- Anna-Lena BergABAnna-Lena Berg
- Margret ArnadottirMAMargret Arnadottir
Open Access
- 21 April 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (5) , 1305-1307
Abstract
In the fifties and the sixties, ACTH was widely used for the treatment of childhood nephrosis probably caused by minimal change disease in most cases [1,2]. This treatment was provided in lieu of steroids since it does not suppress the adrenal glands and there were hopes of less growth stunting. There are a few reported cases of ACTH treatment in nephrotic patients who had not been biopsied but probably suffered from other diseases than minimal change disease [3,4]. These patients received huge doses of short-acting ACTH for days or weeks and some of then seemed to respond, at least partially. During the last few decades the use of ACTH has been limited due to the fact that the preparation must be given parenterally.Keywords
This publication has 9 references indexed in Scilit:
- Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injuryAmerican Journal of Kidney Diseases, 2000
- Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathyKidney International, 1999
- Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patientsKidney International, 1997
- A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathyKidney International, 1995
- A controlled trial of cyclosporine in patients with progressive membranous nephropathyKidney International, 1995
- Lipids and the kidneyKidney International, 1994
- Direct effects of corticotropin on plasma lipoprotein metabolism in man—Studies in vivo and in vitroMetabolism, 1994
- Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuriaKidney International, 1993
- LONG-TERM STEROID-IMMUNOSUPPRESSIVE TREATMENT OF THE CHILDHOOD NEPHROTIC SYNDROMEPediatrics, 1971